BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms responsible for disruption of this well-organized system are the subject of intensive investigations, the exact processes controlling the cardiac sympathetic nervous system are still not fully understood. A conditional knockout of the Hif1a gene was reported to affect the development of sympathetic ganglia and sympathetic innervation of the heart. This study characterized how the combination of HIF-1α deficiency and streptozotocin (STZ)-induced diabetes affects the cardiac sympathetic nervous system and heart function of adult animals. METHODS: Molecular characteristics of Hif1a deficient sympathetic neurons were identified by RNA sequencing. Diabetes was induced in Hif1a knockout and control mice by low doses of STZ treatment. Heart function was assessed by echocardiography. Mechanisms involved in adverse structural remodeling of the myocardium, i.e. advanced glycation end products, fibrosis, cell death, and inflammation, was assessed by immunohistological analyses. RESULTS: We demonstrated that the deletion of Hif1a alters the transcriptome of sympathetic neurons, and that diabetic mice with the Hif1a-deficient sympathetic system have significant systolic dysfunction, worsened cardiac sympathetic innervation, and structural remodeling of the myocardium. CONCLUSIONS: We provide evidence that the combination of diabetes and the Hif1a deficient sympathetic nervous system results in compromised cardiac performance and accelerated adverse myocardial remodeling, associated with the progression of diabetic cardiomyopathy.

Charles University Prague Czechia

Institute of Anatomy Charles University Prague Czechia

Institute of Physiology CAS Prague Czechia

Laboratory of Gene Expression Institute of Biotechnology CAS BIOCEV Vestec Czechia

Laboratory of Molecular Pathogenetics Institute of Biotechnology CAS BIOCEV Vestec Czechia

Zobrazit více v PubMed

Kimura K, Ieda M, Fukuda K. Development, maturation, and transdifferentiation of cardiac sympathetic nerves. Circ Res. 2012;110(2):325–336. doi: 10.1161/CIRCRESAHA.111.257253. PubMed DOI

Kreipke RE, Birren SJ. Innervating sympathetic neurons regulate heart size and the timing of cardiomyocyte cell cycle withdrawal. J Physiol. 2015;593(23):5057–5073. doi: 10.1113/JP270917. PubMed DOI PMC

Zaglia T, Milan G, Franzoso M, Bertaggia E, Pianca N, Piasentini E, Voltarelli VA, Chiavegato D, Brum PC, Glass DJ, et al. Cardiac sympathetic neurons provide trophic signal to the heart via beta2-adrenoceptor-dependent regulation of proteolysis. Cardiovasc Res. 2013;97(2):240–250. doi: 10.1093/cvr/cvs320. PubMed DOI

Irie T, Yamakawa K, Hamon D, Nakamura K, Shivkumar K, Vaseghi M. Cardiac sympathetic innervation via middle cervical and stellate ganglia and antiarrhythmic mechanism of bilateral stellectomy. Am J Physiol Heart Circ Physiol. 2017;312(3):H392–H405. doi: 10.1152/ajpheart.00644.2016. PubMed DOI PMC

Pardini BJ, Lund DD, Schmid PG. Organization of the sympathetic postganglionic innervation of the rat heart. J Auton Nerv Syst. 1989;28(3):193–201. doi: 10.1016/0165-1838(89)90146-X. PubMed DOI

Nam J, Onitsuka I, Hatch J, Uchida Y, Ray S, Huang S, Li W, Zang H, Ruiz-Lozano P, Mukouyama YS. Coronary veins determine the pattern of sympathetic innervation in the developing heart. Development. 2013;140(7):1475–1485. doi: 10.1242/dev.087601. PubMed DOI PMC

Vaseghi M, Shivkumar K. The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis. 2008;50(6):404–419. doi: 10.1016/j.pcad.2008.01.003. PubMed DOI PMC

Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585–607. doi: 10.1038/s41569-020-0339-2. PubMed DOI PMC

Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624–638. doi: 10.1161/CIRCRESAHA.117.311586. PubMed DOI PMC

Falcao-Pires I, Leite-Moreira AF. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev. 2012;17(3):325–344. doi: 10.1007/s10741-011-9257-z. PubMed DOI

Seferovic PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 2015;36(27):1718–1727. doi: 10.1093/eurheartj/ehv134. PubMed DOI

Paolillo S, Rengo G, Pagano G, Pellegrino T, Savarese G, Femminella GD, Tuccillo M, Boemio A, Attena E, Formisano R, et al. Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study. Diabetes Care. 2013;36(8):2395–2401. doi: 10.2337/dc12-2147. PubMed DOI PMC

Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeifer MA, Schwaiger M. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation. 1998;98(10):961–968. doi: 10.1161/01.CIR.98.10.961. PubMed DOI

Ieda M, Kanazawa H, Ieda Y, Kimura K, Matsumura K, Tomita Y, Yagi T, Onizuka T, Shimoji K, Ogawa S, et al. Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts. Circulation. 2006;114(22):2351–2363. doi: 10.1161/CIRCULATIONAHA.106.627588. PubMed DOI

Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med. 2011;365(6):537–547. doi: 10.1056/NEJMra1011165. PubMed DOI

Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399–408. doi: 10.1016/j.cell.2012.01.021. PubMed DOI PMC

Bohuslavova R, Kolar F, Kuthanova L, Neckar J, Tichopad A, Pavlinkova G. Gene expression profiling of sex differences in HIF1-dependent adaptive cardiac responses to chronic hypoxia. J Appl Physiol. 2010;109(4):1195–1202. doi: 10.1152/japplphysiol.00366.2010. PubMed DOI

Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK, Semenza GL, Polotsky VY. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics. 2006;25(3):450–457. doi: 10.1152/physiolgenomics.00293.2005. PubMed DOI

Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, Liu YV, Zhang H, Strazza M, Rey S, Savino L, et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res. 2007;101(12):1310–1318. doi: 10.1161/CIRCRESAHA.107.153346. PubMed DOI

Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, Prabhakar NR. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol. 2006;577(Pt 2):705–716. doi: 10.1113/jphysiol.2006.114033. PubMed DOI PMC

Botusan IR, Sunkari VG, Savu O, Catrina AI, Grunler J, Lindberg S, Pereira T, Yla-Herttuala S, Poellinger L, Brismar K, et al. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci USA. 2008;105(49):19426–19431. doi: 10.1073/pnas.0805230105. PubMed DOI PMC

Liu L, Marti GP, Wei X, Zhang X, Zhang H, Liu YV, Nastai M, Semenza GL, Harmon JW. Age-dependent impairment of HIF-1alpha expression in diabetic mice: correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells. J Cell Physiol. 2008;217(2):319–327. doi: 10.1002/jcp.21503. PubMed DOI PMC

Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes. 2004;53(12):3226–3232. doi: 10.2337/diabetes.53.12.3226. PubMed DOI

Sousa Fialho MDL, Purnama U, Dennis K, Montes Aparicio CN, Castro-Guarda M, Massourides E, Tyler DJ, Carr CA, Heather LC. Activation of HIF1alpha rescues the hypoxic response and reverses metabolic dysfunction in the diabetic heart. Diabetes. 2021;70(11):2518–2531. doi: 10.2337/db21-0398. PubMed DOI PMC

Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, Berrino L, Rossi F, Giugliano D. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia. 2002;45(8):1172–1181. doi: 10.1007/s00125-002-0882-x. PubMed DOI

Cerychova R, Pavlinkova G. HIF-1, metabolism, and diabetes in the embryonic and adult heart. Front Endocrinol (Lausanne) 2018;9:460. doi: 10.3389/fendo.2018.00460. PubMed DOI PMC

Catrina SB, Zheng X. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia. 2021;64(4):709–716. doi: 10.1007/s00125-021-05380-z. PubMed DOI PMC

Bohuslavova R, Kolar F, Sedmera D, Skvorova L, Papousek F, Neckar J, Pavlinkova G. Partial deficiency of HIF-1alpha stimulates pathological cardiac changes in streptozotocin-induced diabetic mice. BMC Endocr Disord. 2014;14:11. doi: 10.1186/1472-6823-14-11. PubMed DOI PMC

Cerychova R, Bohuslavova R, Papousek F, Sedmera D, Abaffy P, Benes V, Kolar F, Pavlinkova G. Adverse effects of Hif1a mutation and maternal diabetes on the offspring heart. Cardiovasc Diabetol. 2018;17(1):68. doi: 10.1186/s12933-018-0713-0. PubMed DOI PMC

Bohuslavova R, Skvorova L, Sedmera D, Semenza GL, Pavlinkova G. Increased susceptibility of HIF-1alpha heterozygous-null mice to cardiovascular malformations associated with maternal diabetes. J Mol Cell Cardiol. 2013;60:129–141. doi: 10.1016/j.yjmcc.2013.04.015. PubMed DOI

Prabhakar NR, Semenza GL. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev. 2012;92(3):967–1003. doi: 10.1152/physrev.00030.2011. PubMed DOI PMC

Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, Marck BT, Matsumoto AM, Shelton JM, Richardson JA, et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice. Nat Genet. 2003;35(4):331–340. doi: 10.1038/ng1266. PubMed DOI

Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998;12(2):149–162. doi: 10.1101/gad.12.2.149. PubMed DOI PMC

Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 1998;12(21):3320–3324. doi: 10.1101/gad.12.21.3320. PubMed DOI PMC

Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci USA. 2000;97(15):8386–8391. doi: 10.1073/pnas.140087397. PubMed DOI PMC

Macias D, Cowburn AS, Torres-Torrelo H, Ortega-Saenz P, Lopez-Barneo J, Johnson RS. HIF-2alpha is essential for carotid body development and function. Elife. 2018;7:e34681. doi: 10.7554/eLife.34681. PubMed DOI PMC

Semenza GL, Prabhakar NR. The role of hypoxia-inducible factors in carotid body (patho) physiology. J Physiol. 2018;596(15):2977–2983. doi: 10.1113/JP275696. PubMed DOI PMC

Qin N, de Cubas AA, Garcia-Martin R, Richter S, Peitzsch M, Menschikowski M, Lenders JW, Timmers HJ, Mannelli M, Opocher G, et al. Opposing effects of HIF1alpha and HIF2alpha on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X. Int J Cancer. 2014;135(9):2054–2064. doi: 10.1002/ijc.28868. PubMed DOI

Ramakrishnan SK, Zhang H, Takahashi S, Centofanti B, Periyasamy S, Weisz K, Chen Z, Uhler MD, Rui L, Gonzalez FJ, et al. HIF2alpha Is an essential molecular brake for postprandial hepatic glucagon response independent of insulin signaling. Cell Metab. 2016;23(3):505–516. doi: 10.1016/j.cmet.2016.01.004. PubMed DOI PMC

Wei K, Piecewicz SM, McGinnis LM, Taniguchi CM, Wiegand SJ, Anderson K, Chan CW, Mulligan KX, Kuo D, Yuan J, et al. A liver Hif-2alpha-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition. Nat Med. 2013;19(10):1331–1337. doi: 10.1038/nm.3295. PubMed DOI PMC

Gunton JE. Hypoxia-inducible factors and diabetes. J Clin Invest. 2020;130(10):5063–5073. doi: 10.1172/JCI137556. PubMed DOI PMC

Bohuslavova R, Cerychova R, Papousek F, Olejnickova V, Bartos M, Gorlach A, Kolar F, Sedmera D, Semenza GL, Pavlinkova G. HIF-1alpha is required for development of the sympathetic nervous system. Proc Natl Acad Sci USA. 2019;116(27):13414–13423. doi: 10.1073/pnas.1903510116. PubMed DOI PMC

Compernolle V, Brusselmans K, Franco D, Moorman A, Dewerchin M, Collen D, Carmeliet P. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Cardiovasc Res. 2003;60(3):569–579. doi: 10.1016/j.cardiores.2003.07.003. PubMed DOI

Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Can Res. 2000;60(15):4010–4015. PubMed

Yang L, Cai CL, Lin L, Qyang Y, Chung C, Monteiro RM, Mummery CL, Fishman GI, Cogen A, Evans S. Isl1Cre reveals a common Bmp pathway in heart and limb development. Development. 2006;133(8):1575–1585. doi: 10.1242/dev.02322. PubMed DOI PMC

Zareen N, Greene LA. Protocol for culturing sympathetic neurons from rat superior cervical ganglia (SCG) J Vis Exp. 2009 doi: 10.3791/988-v. PubMed DOI PMC

Mamanova L, Miao Z, Jinat A, Ellis P, Shirley L, Teichmann SA. High-throughput full-length single-cell RNA-seq automation. Nat Protoc. 2021;16(6):2886–2915. doi: 10.1038/s41596-021-00523-3. PubMed DOI

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. doi: 10.1093/bioinformatics/bts635. PubMed DOI PMC

Martin JA, Wang Z. Next-generation transcriptome assembly. Nat Rev Genet. 2011;12(10):671–682. doi: 10.1038/nrg3068. PubMed DOI

Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi: 10.1093/bioinformatics/btu170. PubMed DOI PMC

Kopylova E, Noe L, Touzet H. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics. 2012;28(24):3211–3217. doi: 10.1093/bioinformatics/bts611. PubMed DOI

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8. PubMed DOI PMC

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi: 10.1101/gr.1239303. PubMed DOI PMC

Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE. 2010;5(11):e13984. doi: 10.1371/journal.pone.0013984. PubMed DOI PMC

Bohuslavova R, Cerychova R, Nepomucka K, Pavlinkova G. Renal injury is accelerated by global hypoxia-inducible factor 1 alpha deficiency in a mouse model of STZ-induced diabetes. BMC Endocr Disord. 2017;17(1):48. doi: 10.1186/s12902-017-0200-8. PubMed DOI PMC

Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–682. doi: 10.1038/nmeth.2019. PubMed DOI PMC

Susaki EA, Tainaka K, Perrin D, Yukinaga H, Kuno A, Ueda HR. Advanced CUBIC protocols for whole-brain and whole-body clearing and imaging. Nat Protoc. 2015;10(11):1709–1727. doi: 10.1038/nprot.2015.085. PubMed DOI

Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308(5728):1583–1587. doi: 10.1126/science.1112062. PubMed DOI

Li C, Li X, Bi Z, Sugino K, Wang G, Zhu T, Liu Z. Comprehensive transcriptome analysis of cochlear spiral ganglion neurons at multiple ages. Elife. 2020;9:e50491. doi: 10.7554/eLife.50491. PubMed DOI PMC

Zheng F, Liu G, Dang T, Chen Q, An Y, Wu M, Kong X, Qiu Z, Wu BL. GABA signaling pathway-associated gene PLCL1 rare variants may be associated with autism spectrum disorders. Neurosci Bull. 2021;37(8):1240–1245. doi: 10.1007/s12264-021-00707-7. PubMed DOI PMC

Kittler JT, Thomas P, Tretter V, Bogdanov YD, Haucke V, Smart TG, Moss SJ. Huntingtin-associated protein 1 regulates inhibitory synaptic transmission by modulating gamma-aminobutyric acid type A receptor membrane trafficking. Proc Natl Acad Sci USA. 2004;101(34):12736–12741. doi: 10.1073/pnas.0401860101. PubMed DOI PMC

Stoeckli ET. Understanding axon guidance: are we nearly there yet? Development. 2018;145(10):dev151415. doi: 10.1242/dev.151415. PubMed DOI

Takeichi M. The cadherin superfamily in neuronal connections and interactions. Nat Rev Neurosci. 2007;8(1):11–20. doi: 10.1038/nrn2043. PubMed DOI

Xia L, Sun J, Xie S, Chi C, Zhu Y, Pan J, Dong B, Huang Y, Xia W, Sha J, et al. PRKAR2B-HIF-1alpha loop promotes aerobic glycolysis and tumour growth in prostate cancer. Cell Prolif. 2020;53(11):e12918. doi: 10.1111/cpr.12918. PubMed DOI PMC

Weise SC, Arumugam G, Villarreal A, Videm P, Heidrich S, Nebel N, Dumit VI, Sananbenesi F, Reimann V, Craske M, et al. FOXG1 regulates PRKAR2B transcriptionally and posttranscriptionally via miR200 in the adult hippocampus. Mol Neurobiol. 2019;56(7):5188–5201. doi: 10.1007/s12035-018-1444-7. PubMed DOI PMC

Hein L, Altman JD, Kobilka BK. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature. 1999;402(6758):181–184. doi: 10.1038/46040. PubMed DOI

Kawano H, Nakatani T, Mori T, Ueno S, Fukaya M, Abe A, Kobayashi M, Toda F, Watanabe M, Matsuoka I. Identification and characterization of novel developmentally regulated neural-specific proteins, BRINP family. Brain Res Mol Brain Res. 2004;125(1–2):60–75. doi: 10.1016/j.molbrainres.2004.04.001. PubMed DOI

Wang Y, Jiang W, Chen H, Zhou H, Liu Z, Liu Z, Liu Z, Zhou Y, Zhou X, Yu L, et al. Sympathetic nervous system mediates cardiac remodeling after myocardial infarction in a circadian disruption model. Front Cardiovasc Med. 2021;8:668387. doi: 10.3389/fcvm.2021.668387. PubMed DOI PMC

Gao PP, Sun CH, Zhou XF, DiCicco-Bloom E, Zhou R. Ephrins stimulate or inhibit neurite outgrowth and survival as a function of neuronal cell type. J Neurosci Res. 2000;60(4):427–436. doi: 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.0.CO;2-D. PubMed DOI

Li H, Wu DK, Sullivan SL. Characterization and expression of sema4g, a novel member of the semaphorin gene family. Mech Dev. 1999;87(1–2):169–173. doi: 10.1016/S0925-4773(99)00125-2. PubMed DOI

Minor K, Tang X, Kahrilas G, Archibald SJ, Davies JE, Davies SJ. Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons. Neurobiol Dis. 2008;32(1):88–95. doi: 10.1016/j.nbd.2008.06.009. PubMed DOI

Brunet I, Gordon E, Han J, Cristofaro B, Broqueres-You D, Liu C, Bouvree K, Zhang J, del Toro R, Mathivet T, et al. Netrin-1 controls sympathetic arterial innervation. J Clin Invest. 2014;124(7):3230–3240. doi: 10.1172/JCI75181. PubMed DOI PMC

Okun E, Griffioen KJ, Rothman S, Wan R, Cong WN, De Cabo R, Martin-Montalvo A, Levette A, Maudsley S, Martin B, et al. Toll-like receptors 2 and 4 modulate autonomic control of heart rate and energy metabolism. Brain Behav Immun. 2014;36:90–100. doi: 10.1016/j.bbi.2013.10.013. PubMed DOI PMC

Zelentsova K, Talmi Z, Abboud-Jarrous G, Sapir T, Capucha T, Nassar M, Burstyn-Cohen T. Protein S regulates neural stem cell quiescence and neurogenesis. Stem Cells. 2017;35(3):679–693. doi: 10.1002/stem.2522. PubMed DOI

Liu D, Guo H, Griffin JH, Fernandez JA, Zlokovic BV. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. Circulation. 2003;107(13):1791–1796. doi: 10.1161/01.CIR.0000058460.34453.5A. PubMed DOI

Kvetnansky R, Sabban EL, Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev. 2009;89(2):535–606. doi: 10.1152/physrev.00042.2006. PubMed DOI

Herold Z, Herold M, Nagy P, Patocs A, Doleschall M, Somogyi A. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis. J Diabetes Investig. 2020;11(4):865–873. doi: 10.1111/jdi.13203. PubMed DOI PMC

Christensen NJ. Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. Diabetes. 1974;23(1):1–8. doi: 10.2337/diab.23.1.1. PubMed DOI

Scognamiglio R, Avogaro A, Casara D, Crepaldi C, Marin M, Palisi M, Mingardi R, Erle G, Fasoli G, Dalla Volta S. Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1998;31(2):404–412. doi: 10.1016/S0735-1097(97)00516-0. PubMed DOI

Watts D, Bechmann N, Meneses A, Poutakidou IK, Kaden D, Conrad C, Kruger A, Stein J, El-Armouche A, Chavakis T, et al. HIF2alpha regulates the synthesis and release of epinephrine in the adrenal medulla. J Mol Med (Berl) 2021;99(11):1655–1666. doi: 10.1007/s00109-021-02121-y. PubMed DOI PMC

Tai TC, Wong-Faull DC, Claycomb R, Wong DL. Hypoxic stress-induced changes in adrenergic function: role of HIF1 alpha. J Neurochem. 2009;109(2):513–524. doi: 10.1111/j.1471-4159.2009.05978.x. PubMed DOI

Richter S, Qin N, Pacak K, Eisenhofer G. Role of hypoxia and HIF2alpha in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features. Adv Pharmacol. 2013;68:285–317. doi: 10.1016/B978-0-12-411512-5.00014-2. PubMed DOI PMC

Schnell PO, Ignacak ML, Bauer AL, Striet JB, Paulding WR, Czyzyk-Krzeska MF. Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors. J Neurochem. 2003;85(2):483–491. doi: 10.1046/j.1471-4159.2003.01696.x. PubMed DOI

Tank AW, Lee Wong D. Peripheral and central effects of circulating catecholamines. Compr Physiol. 2015;5(1):1–15. PubMed

van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117(1):43–51. doi: 10.1161/CIRCULATIONAHA.107.728550. PubMed DOI

Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res. 2003;92(7):785–792. doi: 10.1161/01.RES.0000065620.39919.20. PubMed DOI

Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia. 2000;43(5):533–549. doi: 10.1007/s001250051341. PubMed DOI

Hyun U, Sohn JW. Autonomic control of energy balance and glucose homeostasis. Exp Mol Med. 2022;54(4):370–376. doi: 10.1038/s12276-021-00705-9. PubMed DOI PMC

Ziegler MG, Elayan H, Milic M, Sun P, Gharaibeh M. Epinephrine and the metabolic syndrome. Curr Hypertens Rep. 2012;14(1):1–7. doi: 10.1007/s11906-011-0243-6. PubMed DOI

Bavkar LN, Patil RS, Rooge SB, Nalawade ML, Arvindekar AU. Acceleration of protein glycation by oxidative stress and comparative role of antioxidant and protein glycation inhibitor. Mol Cell Biochem. 2019;459(1–2):61–71. doi: 10.1007/s11010-019-03550-7. PubMed DOI

Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N, Gugliucci A, Kapahi P. The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metab. 2018;28(3):337–352. doi: 10.1016/j.cmet.2018.08.014. PubMed DOI PMC

Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2016;90:84–93. doi: 10.1016/j.yjmcc.2015.12.011. PubMed DOI PMC

Bashey RI, Martinez-Hernandez A, Jimenez SA. Isolation, characterization, and localization of cardiac collagen type VI. Associations with other extracellular matrix components. Circ Res. 1992;70(5):1006–1017. doi: 10.1161/01.RES.70.5.1006. PubMed DOI

Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 2003;112(5):645–657. doi: 10.1016/S0092-8674(03)00154-5. PubMed DOI PMC

Moskalik A, Niderla-Bielińska J, Ratajska A. Multiple roles of cardiac macrophages in heart homeostasis and failure. Heart Fail Rev. 2022;27(4):1413–1430. doi: 10.1007/s10741-021-10156-z. PubMed DOI PMC

Duim SN, Kurakula K, Goumans MJ, Kruithof BP. Cardiac endothelial cells express Wilms' tumor-1: Wt1 expression in the developing, adult and infarcted heart. J Mol Cell Cardiol. 2015;81:127–135. doi: 10.1016/j.yjmcc.2015.02.007. PubMed DOI

Li N, Rignault-Clerc S, Bielmann C, Bon-Mathier AC, Deglise T, Carboni A, Ducrest M, Rosenblatt-Velin N. Increasing heart vascularisation after myocardial infarction using brain natriuretic peptide stimulation of endothelial and WT1(+) epicardial cells. Elife. 2020;9:e61050. doi: 10.7554/eLife.61050. PubMed DOI PMC

Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation. 2002;105(14):1727–1733. doi: 10.1161/01.CIR.0000012466.50373.E8. PubMed DOI

Schmid H, Forman LA, Cao X, Sherman PS, Stevens MJ. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes. 1999;48(3):603–608. doi: 10.2337/diabetes.48.3.603. PubMed DOI

Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012;8(7):405–416. doi: 10.1038/nrendo.2012.21. PubMed DOI

Cullum NA, Mahon J, Stringer K, McLean WG. Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus. Diabetologia. 1991;34(6):387–389. doi: 10.1007/BF00403175. PubMed DOI

Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, Silver M, Krainin JG, Weinberg DH, Ropper AH, et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest. 2001;107(9):1083–1092. doi: 10.1172/JCI12188. PubMed DOI PMC

Rojas DR, Tegeder I, Kuner R, Agarwal N. Hypoxia-inducible factor 1alpha protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species. J Mol Med (Berl) 2018;96(12):1395–1405. doi: 10.1007/s00109-018-1707-9. PubMed DOI

Misur I, Zarkovic K, Barada A, Batelja L, Milicevic Z, Turk Z. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy. Acta Diabetol. 2004;41(4):158–166. doi: 10.1007/s00592-004-0160-0. PubMed DOI

Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care. 2011;34(2):442–447. doi: 10.2337/dc10-1087. PubMed DOI PMC

Sixty Years of Heart Research in the Institute of Physiology of the Czech Academy of Sciences

Reprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposure